Isorhapontigenin ameliorates cerebral ischemia/reperfusion injury via modulating Kinase Cε/Nrf2/HO‐1 signaling pathway
Abstract Background Isorhapontigenin (ISO) has been shown to have antioxidant activity. This study aimed to investigate the antioxidant effects of ISO on cerebral ischemia/reperfusion (I/R) injury and its possible molecular mechanisms. Methods Focal cerebral ischemia‐reperfusion injury (MCAO/R) mode...
Main Authors: | Zhe Xue, Kai Zhao, Zhenghui Sun, Chen Wu, Bowen Yu, Dongsheng Kong, Bainan Xu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-07-01
|
Series: | Brain and Behavior |
Subjects: | |
Online Access: | https://doi.org/10.1002/brb3.2143 |
Similar Items
-
Pelargonidin ameliorates MCAO-induced cerebral ischemia/reperfusion injury in rats by the action on the Nrf2/HO-1 pathway
by: Fu Kong, et al.
Published: (2021-01-01) -
Pre-clinical Pharmacokinetic and Metabolomic Analyses of Isorhapontigenin, a Dietary Resveratrol Derivative
by: Yu Dai, et al.
Published: (2018-07-01) -
The Nrf2/HO-1 Pathway Mediates the Antagonist Effect of L-Arginine On Renal Ischemia/Reperfusion Injury in Rats
by: Fei Tong, et al.
Published: (2017-08-01) -
Piceatannol and Its Metabolite, Isorhapontigenin, Induce SIRT1 Expression in THP-1 Human Monocytic Cell Line
by: Shinpei Kawakami, et al.
Published: (2014-10-01) -
Isorhapontigenin protects against doxorubicin-induced cardiotoxicity via increasing YAP1 expression
by: Panxia Wang, et al.
Published: (2021-03-01)